MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective

References

• Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998;41:307–17.
   PubMed Web of Science ®Google Scholar
• Horiot JC, Pigneux J, Pourquier H, Schraub S, Achille E, Keiling R, et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: A French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 1988;14:605–11.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Creutzberg CL, Craighead PS, McCormack M, Toita T, Narayan K, et al. International brachytherapy practice patterns: A survey of the gynecological cancer intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012;82:250–5.
   PubMed Web of Science ®Google Scholar
• Pötter R, van Limbergen E, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001;58: 11–8.
   PubMed Web of Science ®Google Scholar
• Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, van Limbergen E. The GEC ESTRO handbook of brachytherapy, 1st ed. Leuven, Belgium: ACCO; 2002.
   Google Scholar
• Eifel PJ. The importance of locoregional control of cervical cancer – why is it still controversial?Cancer J Sci Am 1996;2:253–5.
   PubMedGoogle Scholar
• Pedersen D, Bentzen SM, Overgaard J. Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix. Acta Oncol 1994;33:547–55.
   PubMed Web of Science ®Google Scholar
• Jakobsen A. External radiation of cervix cancer with a concomittant boost. Int J Gynecol Cancer 2004;14:11–2.
   Google Scholar
• Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New Engl J Med 1999;340:1144–53.
   PubMed Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Jr. et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339–48.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Potter R. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282–7.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Hokland SB, Rohl L, Pedersen EM, Nielsen SK, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013;107:63–8.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Wang JZ, Lo SS, Zhang D, Grecula JC, Lu L, et al. Translating response during therapy into ultimate treatment outcome: A personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer. Int J Radiat Oncol Biol Phys 2010;76:719–27.
   PubMed Web of Science ®Google Scholar
• Andersen EK, Kristensen GB, Lyng H, Malinen E. Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers. Acta Oncol 2011;50:859–65.
   PubMed Web of Science ®Google Scholar
• Pötter R. Image-guided brachytherapy sets benchmarks in advanced radiotherapy. Radiother Oncol 2009;91:141–6.
   PubMed Web of Science ®Google Scholar
• Haack S, Pedersen EM, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol 2010;49:978–83.
   PubMed Web of Science ®Google Scholar
• Pötter R, Haie-Meder C, Limbergen EV, Barillot I, Brabandere MD, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Potter R, van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
   PubMed Web of Science ®Google Scholar
• Pötter R, Dimopoulos J. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116–23.
   PubMed Web of Science ®Google Scholar
• Pötter R, Dimopoulos J, Georg P, Lang S, Waldhausl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148–55.
   PubMed Web of Science ®Google Scholar
• Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study. Radiother Oncol 2012;103:305–13.
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magne N. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010;96:161–5.
   PubMed Web of Science ®Google Scholar
• Chargari C, Magne N, Dumas I, Messai T, Vicenzi L, Gillion N, et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009;74:133–9.
   PubMed Web of Science ®Google Scholar
• Wanderas AD, Sundset M, Langdal I, Danielsen S, Frykholm G, Marthinsen AB. Adaptive brachytherapy of cervical cancer, comparison of conventional point A and CT based individual treatment planning. Acta Oncol 2012;51:345–54.
   PubMed Web of Science ®Google Scholar
• Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience. Radiother Oncol 2013;107:69–74.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed dose rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:756–64.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Nielsen SK, Nyvang G, Pedersen EP, Røhl L, Fokdal L, et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010;94:173–80.
   PubMed Web of Science ®Google Scholar
• Benedet JL, Bender H, Jones H, III, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70:209–62.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Havsteen H, Christensen JJ, Tanderup K, Jakobsen A. Treatment outcome following replacement of continuous MDR with remote afterloading PDR brachytherapy in the treatment of advanced cervical cancer. Radiother Oncol 2000;56:S102.
   Google Scholar
• Dimopoulos JC, Kirisits C, Petric P, Georg P, Lang S, Berger D, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006;66:83–90.
   PubMed Web of Science ®Google Scholar
• Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Potter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006;65:624–30.
   PubMed Web of Science ®Google Scholar
• Andersen ES, Noe KO, Sorensen TS, Nielsen SK, Fokdal L, Paludan M, et al. Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy. Radiother Oncol 2013;107:52–7.
   PubMed Web of Science ®Google Scholar
• Cadron I, Jakobsen A, Vergote I. Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer. Gynecol Obstet Invest 2005;59:126–9.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–6.
   PubMed Web of Science ®Google Scholar
• Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–81.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Lindegaard JC, Kirisits C, Nkiwane K, Fidarova E, Haie-Meder C, et al. Embrace update. Radiother Oncol 2011;99:S22–3.
   Google Scholar
• Lindegaard JC, Fokdal L, Nielsen SK, Røhl L, Pedersen EM, Petersen LK, et al. Outcome of image guided adaptive brachytherapy in locally advanced cervical cancer. Radiother Oncol 2012;103:S41–2.
   Google Scholar
• Lindegaard JC, Haie-Meder C, Brunaud C, van Limbergen E, Kirisits C, Pötter R. Cervix cancer: Image guided adaptive brachytherapy in the setting of definitive radio-chemotherapy – status of current multi-centre studies. Radiother Oncol 2011;99:S226–7.
   Google Scholar
• Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105:103–4.
   PubMed Web of Science ®Google Scholar
• Thomeer MG, Gerestein C, Spronk S, van Doorn HC, van der HE, Hunink MG. Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: Systematic review and meta-analysis. Eur Radiol 2013;23:2005–18.
   PubMed Web of Science ®Google Scholar
• Stenstedt K, Hellstrom AC, Fridsten S, Blomqvist L. Impact of MRI in the management and staging of cancer of the uterine cervix. Acta Oncol 2011;50:420–6.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Ljungstroem B, Nyland M, Jakobsen A. Radical hysterectomy in cervical carcinoma stage Ib. Eur J Gynaecol Oncol 1990;11:13–7.
   PubMedGoogle Scholar
• Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer. a systematic review and meta- analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802–12.
   PubMed Web of Science ®Google Scholar
• Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Luttmann S, et al. Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage. Acta Oncol 2012;51:915–21.
   PubMed Web of Science ®Google Scholar
• Tattersall MHN. Concomitant and neoadjuvant chemotherapy in conjunction with radiotherapy in the management of locally advanced cervical cancer. J Natl Cancer Inst Monogr 1996;21:101–3.
   PubMedGoogle Scholar
• Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, et al. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: An inter-era analysis. Int J Radiat Oncol Biol Phys 2012;84:973–82.
   PubMed Web of Science ®Google Scholar
• Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999; 43:763–75.
   PubMed Web of Science ®Google Scholar
• Alevronta E, Lind H, Al-Abany M, Waldenstrom AC, Olsson C, Dunberger G, et al. Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy. Acta Oncol 2013;52:719–26.
   PubMed Web of Science ®Google Scholar
• Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008;47:1337–43.
   PubMed Web of Science ®Google Scholar
• Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Potter R. Image-guided radiotherapy for cervix cancer: High-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008;71:1272–8.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Georg D, Pötter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy. Sem Radiat Oncol 2010;20:121–9.
   PubMed Web of Science ®Google Scholar
• Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose- positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2009;77:1085–91.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75:56–63.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Fokdal L, Sturdza AE, Mazeron R, Kirisits C, Lindegaard JC, et al. Dose-response for local control in image guided cervix brachytherapy in the retro EMBRACE study. Radiother Oncol 2013;106:S103–4.
   Google Scholar
• Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872–80.
   PubMed Web of Science ®Google Scholar
• Perez CA. Utererine cervix. In: Perez CA, Brady LW, editors. Principle and practice of radiation oncology. Philadelphia: Lippincott-Raven; 1997. pp 1733–834.
   Google Scholar
• Pötter R, Kirisits C, Fidarova EF, Dimopoulos JC, Berger D, Tanderup K, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325–36.
   PubMed Web of Science ®Google Scholar